The largest database of trusted experimental protocols

2 protocols using hif 1 sirna

1

Silencing Key Regulators in Glioma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
U251 and U87 human glioma cells were transfected at 80% confluence with SCAP siRNA (cat. no. sc-36462; Santa Cruz Biotechnology, Inc.), hypoxia-inducible factor 1 (HIF-1) siRNA (cat. no. sc-35561; Santa Cruz Biotechnology, Inc.), SREBP-1 siRNA (cat. no. sc-36557; Santa Cruz Biotechnology, Inc.) and control siRNA (cat. no. sc-37007; Santa Cruz Biotechnology, Inc.) using Lipofectamine® 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's instructions. Briefly, prior to treatment, Lipofectamine® 2000 (Invitrogen; Thermo Fisher Scientific, Inc.)/siRNA complexes were prepared in Opti-MEM medium, at the ratio of 1 μl Lipofectamine 2000 per 20 pmole siRNA. Cells then were then treated at 37°C for 48 h before being replaced with complete medium for the desired duration. The transfection efficiency of the cells was verified by western blotting.
+ Open protocol
+ Expand
2

Metabolic Regulation in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unless specified, all reagents were obtained from Sigma and all the antibodies were from Santa Cruz Biotechnology, except for anti-HIF-1α (Becton Dickinson), anti-PKM2 and anti-Src-Tyr416 (Cell Signaling Technology) and anti phospho-Tyr (clone 4G10) (Millipore). HRP-conjugated streptavidin was from Pierce. HIF-1-siRNA and DEC1-siRNA were from Santa Cruz Biotechnology. N-(biotinoyl)-N-(iodoacetyl)ethylenediamine (BIAM) and 2′-7′-dichlorofluoresceindiacetate (H2-DCF-DA) were from Molecular Probe. [U-14C] lactate and [U-14C] glucose were from Perkin Elmer. All the kits used to perform miRNA extraction and quantitative reverse transcriptase PCR were from Qiagen. Lipofectamine 2000 was from Invitrogen. Metformin was obtained by Sigma. The chemical synthesis of the PKM2 activator DASA-58 was kindly performed by Dr. Richichi of the Department of Chemistry (University of Florence). The mitochondrial antioxidant MitoTEMPO was from Santa Cruz Biotechnology. The MCT1 inhibitor, AR-C155858, was from Tocris Bioscience.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!